Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz - 2Everyday Seasonal Positions That Compensate Fairly in the US
- 3Yemen’s Aden airport shut by STC-backed transport minister, Saudi source says
- 4Doctors seek to understand why quitting antidepressants causes withdrawal for some
- 5Brazil's former President Jair Bolsonaro seeks house arrest for prison time citing health issues
- The gay hockey show no one saw coming — and everyone is suddenly obsessed with
- French rapper Gims placed under investigation for 'aggravated money laundering'
- Churches and politicians in South Sudan call for 'lasting peace' in Easter messages
- Pocket-Accommodating Jeep Wrangler Buying Guide for Seniors
- Find the Advantages of Careful Eating: Developing a Sound Connection with Food
- Astronauts welcome arrival of new crewmates | On the International Space Station this week Nov. 24-28, 2025
- The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- NASA wants to build a base on the Moon by the 2030s – how and why it plans to build up to a long-term lunar presence
- Pick Your Favored kind of sandwich
